This company has shut down. Peptyde Bio is no longer operating — its last tracked round was a Pre-Seed in 2022.
Explore the Startup GraveyardPeptyde Bio is an Agtech startup positioned to become the go-to supplier of new AMPs.
Peptyde Bio has raised $1.2M in total funding. The most recent round was Pre-Seed. The last funding was announced in November 2022.
Peptyde Bio's investors include BioGenerator, Wells Fargo Innovation Incubator, QRM Capital, St. Louis Arch Angels, Danforth Technology Company.
Peptyde Bio is headquartered in St Louis, United States.
Peptyde Bio is an Agtech startup positioned to become the go-to supplier of new AMPs.
Peptyde Bio is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Peptyde Bio — Funding & Investors." VCBacked, November 15, 2022, https://www.vcbacked.co/company/peptyde-bio. Accessed August 14, 2026.
VCBacked. (2022). Peptyde Bio — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/peptyde-bio
{{cite web |title=Peptyde Bio — Funding & Investors |url=https://www.vcbacked.co/company/peptyde-bio |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated